The price is currently a reflection of the FUD generated by the BOD by not making any announcement on the pending USPTO reexamination actions. After the company confirmed the status of the 336 certification, a simple statement regarding our legal interpretation of these new actions would have mitigated the FUD; but no statement translates to anguish that is relieved through stock sales. Investors that better understand USPTO actions are definitely scooping these shares up. As we all can see, the BOD is dormant in actions to provide any price support.